Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Katherine Tzou

Concepts (105)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
7
2019
913
1.030
Why?
Radiosurgery
3
2019
299
0.690
Why?
Prostate-Specific Antigen
4
2022
150
0.630
Why?
Neoplasm Recurrence, Local
4
2017
850
0.530
Why?
Databases, Factual
2
2019
1125
0.510
Why?
Radium
2
2022
3
0.350
Why?
Salvage Therapy
6
2017
127
0.340
Why?
Prostatic Neoplasms, Castration-Resistant
2
2022
40
0.330
Why?
Bone Neoplasms
2
2022
191
0.290
Why?
Melanoma
2
2022
620
0.210
Why?
Radiation Injuries
2
2013
128
0.200
Why?
Prostatectomy
4
2017
97
0.190
Why?
Meta-Analysis as Topic
1
2022
156
0.180
Why?
Aged, 80 and over
8
2019
6306
0.180
Why?
Neuroma, Acoustic
1
2019
32
0.160
Why?
Dura Mater
1
2017
27
0.150
Why?
Drug Resistance, Neoplasm
1
2022
636
0.140
Why?
GATA2 Transcription Factor
1
2017
12
0.140
Why?
Kallikreins
1
2016
28
0.140
Why?
Prognosis
3
2019
3315
0.140
Why?
Meningeal Neoplasms
1
2017
86
0.140
Why?
Hepatocyte Nuclear Factor 3-alpha
1
2016
9
0.130
Why?
Patient Reported Outcome Measures
1
2018
251
0.130
Why?
Biomarkers, Tumor
1
2022
1032
0.130
Why?
MicroRNAs
1
2022
600
0.130
Why?
Aged
9
2019
18969
0.120
Why?
Glioblastoma
1
2017
250
0.120
Why?
Data Collection
1
2018
618
0.120
Why?
Prostate
1
2016
157
0.120
Why?
Middle Aged
10
2019
26605
0.120
Why?
Male
14
2022
55396
0.110
Why?
Rectal Diseases
1
2013
17
0.110
Why?
Retrospective Studies
6
2022
12521
0.110
Why?
Radiotherapy, Conformal
1
2013
68
0.110
Why?
Follow-Up Studies
2
2019
4392
0.110
Why?
Brachytherapy
1
2013
100
0.100
Why?
Chemotherapy, Adjuvant
2
2017
332
0.100
Why?
Embolization, Therapeutic
1
2013
178
0.090
Why?
Practice Patterns, Physicians'
1
2019
1175
0.090
Why?
Treatment Failure
1
2011
330
0.080
Why?
Humans
16
2022
114045
0.080
Why?
Liver Neoplasms
1
2013
504
0.080
Why?
Skin Neoplasms
1
2016
754
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
1356
0.080
Why?
Adult
6
2019
30375
0.080
Why?
Neoplasm Staging
3
2017
1162
0.080
Why?
Combined Modality Therapy
3
2017
1117
0.070
Why?
Radiotherapy, Adjuvant
1
2007
182
0.070
Why?
Medulloblastoma
1
2007
172
0.060
Why?
Radiotherapy Dosage
2
2017
243
0.060
Why?
Neoplasm Metastasis
2
2017
521
0.060
Why?
Treatment Outcome
4
2022
9049
0.060
Why?
Interleukin-15
1
2004
74
0.060
Why?
Neoplasms, Experimental
1
2004
149
0.060
Why?
Survival Analysis
2
2017
1206
0.050
Why?
Interleukin-2
1
2004
413
0.050
Why?
Immunotherapy, Adoptive
1
2004
184
0.050
Why?
Brain Neoplasms
1
2007
966
0.040
Why?
Watchful Waiting
1
2019
54
0.040
Why?
Risk Factors
3
2017
8614
0.040
Why?
Lomustine
1
2017
14
0.040
Why?
Neurosurgical Procedures
1
2019
150
0.040
Why?
Craniotomy
1
2017
68
0.040
Why?
T-Lymphocytes
1
2004
1735
0.030
Why?
Fatal Outcome
1
2017
281
0.030
Why?
Immunoenzyme Techniques
1
2017
192
0.030
Why?
Aminoquinolines
1
2016
19
0.030
Why?
Ipilimumab
1
2016
27
0.030
Why?
Administration, Topical
1
2016
137
0.030
Why?
Coloring Agents
1
2016
72
0.030
Why?
Multivariate Analysis
1
2019
1422
0.030
Why?
Risk Assessment
2
2015
2958
0.030
Why?
Contrast Media
1
2017
347
0.030
Why?
Kaplan-Meier Estimate
1
2016
813
0.030
Why?
Proportional Hazards Models
1
2017
1078
0.030
Why?
Organs at Risk
1
2013
30
0.030
Why?
Organ Sparing Treatments
1
2013
31
0.030
Why?
Dose-Response Relationship, Radiation
1
2013
127
0.030
Why?
Yttrium Radioisotopes
1
2013
51
0.030
Why?
Radiation Protection
1
2013
34
0.030
Why?
Microspheres
1
2013
123
0.030
Why?
United States
2
2019
12137
0.020
Why?
Young Adult
2
2019
10444
0.020
Why?
Radiography
1
2013
803
0.020
Why?
Prospective Studies
1
2022
6195
0.020
Why?
Female
5
2019
59324
0.020
Why?
Survival Rate
1
2013
1638
0.020
Why?
Sensitivity and Specificity
1
2013
1690
0.020
Why?
Tomography, X-Ray Computed
1
2017
2272
0.020
Why?
Time Factors
1
2018
6077
0.020
Why?
Incidence
1
2013
2314
0.020
Why?
Antineoplastic Agents
1
2017
1875
0.020
Why?
Magnetic Resonance Imaging
1
2017
3039
0.020
Why?
Reproducibility of Results
1
2013
2764
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2004
211
0.010
Why?
Clinical Trials as Topic
1
2007
926
0.010
Why?
Immunologic Memory
1
2004
313
0.010
Why?
Mice, Inbred BALB C
1
2004
1144
0.010
Why?
Adolescent
1
2019
17800
0.010
Why?
Lymphocyte Activation
1
2004
1036
0.010
Why?
Infant, Newborn
1
2007
5038
0.010
Why?
Infant
1
2007
7943
0.010
Why?
Child, Preschool
1
2007
9114
0.010
Why?
Mice
1
2004
14843
0.000
Why?
Animals
1
2004
31565
0.000
Why?
Tzou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)